Literature DB >> 19500112

A change in pituitary magnetic resonance imaging protocol detects ACTH-secreting tumours in patients with previously negative results.

Iffat N Chowdhury1, Ninet Sinaii, Edward H Oldfield, Nicholas Patronas, Lynnette K Nieman.   

Abstract

OBJECTIVE: While detection of pituitary tumours with magnetic resonance imaging (MRI) may reduce diagnostic costs and improve surgical outcomes for patients with Cushing's disease, the optimal T1-weighted spin-echo (SE) MRI protocol remains unknown. We hypothesized that specific MR scanning parameters influence detection of corticotropinomas. DESIGN AND PATIENTS: Between December 1997 and November 2004, 21 of 84 consecutive patients with Cushing's disease had a falsely negative initial pituitary MRI study and a lesion identified subsequently at the National Institutes of Health Clinical Center. This study retrospectively reviewed and compared technical parameters used for the two pituitary T1-weighted SE MRIs in 18 patients with available scans. MEASUREMENTS: Repetition time (TR)/echo times (TE), field of view (FOV), matrix size, magnetic field strength, slice thickness, use of gadolinium contrast and the time interval between studies were recorded.
RESULTS: The MRI interscan interval was 5.4 +/- 1.1 months. All scans used gadolinium, matrix sizes were similar and nearly all had 3-mm thick slices. Parameters that differed between the NIH- and externally performed scans were: TR (400 ms vs. 492 +/- 19 ms, P = 0.0002); TE (10.3 +/- 0.5 vs. 17.2 +/- 1.2 ms, P = 0.0003); FOV (12 x 12 cm vs.17 +/- 0.6 x 18 +/- 0.7 cm, P < 0.0001). Immunohistochemistry of tumours resected at transsphenoidal surgery confirmed all to be corticotropinomas.
CONCLUSIONS: Not all 'T1-weighted SE' scans are equally accurate. MRI technique, particularly FOV and TR/TE value, influences results. We recommend that endocrinologists consider pituitary MRI parameters when interpreting the results.

Entities:  

Mesh:

Year:  2009        PMID: 19500112      PMCID: PMC2866063          DOI: 10.1111/j.1365-2265.2009.03646.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

Review 1.  Magnetic resonance imaging of pituitary and parasellar abnormalities.

Authors:  D W Chakeres; A Curtin; G Ford
Journal:  Radiol Clin North Am       Date:  1989-03       Impact factor: 2.303

2.  Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.

Authors:  A Tabarin; F Laurent; B Catargi; F Olivier-Puel; R Lescene; J Berge; F S Galli; J Drouillard; P Roger; J Guerin
Journal:  Clin Endocrinol (Oxf)       Date:  1998-09       Impact factor: 3.478

3.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  High-resolution MR imaging of pituitary microadenomas at 1.5 T: experience with Cushing disease.

Authors:  W W Peck; W P Dillon; D Norman; T H Newton; C B Wilson
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

5.  Comparison of magnetic resonance imaging and computed tomography in the preoperative evaluation of pituitary adenomas.

Authors:  D A Nichols; E R Laws; O W Houser; C F Abboud
Journal:  Neurosurgery       Date:  1988-02       Impact factor: 4.654

6.  Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.

Authors:  Sylvie Salenave; Blandine Gatta; Sylvie Pecheur; François San-Galli; André Visot; Pierre Lasjaunias; Patrick Roger; Jérôme Berge; Jacques Young; Antoine Tabarin; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

7.  Pituitary adenomas: high-resolution MR imaging at 1.5 T.

Authors:  W Kucharczyk; D O Davis; W M Kelly; G Sze; D Norman; T H Newton
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

8.  Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland.

Authors:  J L Doppman; J A Frank; A J Dwyer; E H Oldfield; D L Miller; L K Nieman; G P Chrousos; G B Cutler; D L Loriaux
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

9.  Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.

Authors:  A J Dwyer; J A Frank; J L Doppman; E H Oldfield; A M Hickey; G B Cutler; D L Loriaux; T F Schiable
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

10.  1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation.

Authors:  M V Kulkarni; K F Lee; C B McArdle; J W Yeakley; F L Haar
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jan-Feb       Impact factor: 3.825

View more
  13 in total

Review 1.  Pituitary magnetic resonance imaging in Cushing's disease.

Authors:  Giovanni Vitale; Fabio Tortora; Roberto Baldelli; Francesco Cocchiara; Rosa Maria Paragliola; Emilia Sbardella; Chiara Simeoli; Ferdinando Caranci; Rosario Pivonello; Annamaria Colao
Journal:  Endocrine       Date:  2016-07-19       Impact factor: 3.633

2.  Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease.

Authors:  Matthew B Potts; Jugal K Shah; Annette M Molinaro; Lewis S Blevins; J Blake Tyrrell; Sandeep Kunwar; Christopher F Dowd; Steven W Hetts; Manish K Aghi
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

3.  High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.

Authors:  Prashant Chittiboina; Blake K Montgomery; Corina Millo; Peter Herscovitch; Russell R Lonser
Journal:  J Neurosurg       Date:  2014-12-05       Impact factor: 5.115

4.  CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.

Authors:  Jacqueline Boyle; Nicholas J Patronas; James Smirniotopoulos; Peter Herscovitch; William Dieckman; Corina Millo; Dragan Maric; Grégoire P Chatain; Christina Piper Hayes; Sarah Benzo; Gretchen Scott; Nancy Edwards; Abhik Ray Chaudhury; Maya B Lodish; Susmeeta Sharma; Lynnette K Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Endocrine       Date:  2019-05-06       Impact factor: 3.633

Review 5.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

6.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

7.  Potential utility of FLAIR in MRI-negative Cushing's disease.

Authors:  Grégoire P Chatain; Nicholas Patronas; James G Smirniotopoulos; Martin Piazza; Sarah Benzo; Abhik Ray-Chaudhury; Susmeeta Sharma; Maya Lodish; Lynnette Nieman; Constantine A Stratakis; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2017-10-13       Impact factor: 5.115

Review 8.  Steroid profiling in the diagnosis of mild and overt Cushing's syndrome.

Authors:  Shobana Athimulam; Stefan Grebe; Irina Bancos
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2021-02-06       Impact factor: 4.690

9.  Internal jugular vein adrenocorticotropic hormone estimation for diagnosis of adrenocorticotropic hormone-dependent Cushing's syndrome: Ultrasound-guided direct jugular vein sample collection.

Authors:  Jaya Prakash Sahoo; Ashu Seith; Nandita Gupta; Sadanand Dwivedi; Ariachery C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2012-11

10.  Precontrast T1 signal measurements of normal pituitary and microadenoma: A retrospective analysis through DCE MRI signal time curves.

Authors:  Ishan Kumar; Tanya Yadav; Ashish Verma; Ram C Shukla; Surya K Singh
Journal:  Indian J Radiol Imaging       Date:  2018 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.